Supporting this hypothesis, emerging evidence indicates that: (1) CLEC-2 exerts an inhibitory effect on platelet aggregation 29; (2) it is significantly downregulated in HCC 30; and (3) it is involved in the metastasis of various cancer types 21. The gene discussed is CLEC1B; the disease is cancer.